Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate

BACKGROUND: Progressive multifocal leukoencephalopathy (PML), a potentially fatal demyelinating disease caused by the John Cunningham virus (JCV), can occur as a complication of treatment with rituximab, fingolimod, and dimethyl fumarate. The primary objective of this study was to determine changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Farley, Stephen, Gottesman, Malcolm H., Friedman-Urevich, Sharon, Ye, Janin, Shen, Mark, Grueneberg, Denise, Martone, Lorraine, Calixte, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743681/
https://www.ncbi.nlm.nih.gov/pubmed/31528397
http://dx.doi.org/10.25259/SNI-4-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743681/
https://www.ncbi.nlm.nih.gov/pubmed/31528397
http://dx.doi.org/10.25259/SNI-4-2019

Ejemplares similares